Skip to main content

Table 1 Characteristics and follow-up outcomes of 15 malignant musculoskeletal tumor patients

From: Use of extended curettage with osteotomy and fenestration followed by reconstruction with conservation of muscle insertion in the treatment of Enneking stage II locally aggressive bone tumor of the proximal extremities: resection and treatment of bone tumors

  Gender Age (years) Site Diagnosis Treatment Follow-up (months) Recurrence (months after surgery) Enneking score Rating of score
  F 22 PH ABC IC+BG 37 - 29 Very good
  M 19 PF ABC IC+BG 47 - 29 Very good
  M 22 PH ABC IC+BG 36 - 29 Very good
  F 27 PF ABC-R IC+BG 72 9 20 Good
  M 21 PF ABC IC+BG 35 - 28 Very good
  F 28 PF ABC-R IC+BG 45 - 29 Very good
  M 27 PF CBT IC+BG 52 - 29 Very good
  M 37 PF GCT IC+BC 46 - 29 Very good
  M 19 PH CBT IC+BG 54 - 29 Very good
  F 33 PF GCT IC+BC 43 - 28 Very good
  F 38 PF GCT IC+BC 66 12 18a Moderatea
  F 42 PH GCT IC+BC 53 - 29 Very good
  M 38 PH CBT IC+BG 45 - 28 Very good
  F 26 PH ABC IC+BG 25 - 19 Good
  M 36 PF GCT IC+BC 67 - 29 Very good
Totals M 8/15 (53%) 29 ±7.75 (18 to 42)b PF: 6/15 (40%) ABC: 7/15 (47%)c IC+BC: 5/15 (33%) 48 ±12.95 (25 to 72)b Two 27 ±4.07 (18 to 29)b Very Good 12/15 (80%)
  F 7/15 (47%)   PH: 9/15 (60%) CBT: 3/15 (20%) IC+BG: 10/15 (66%) PH: 42 ±11.2 (25 to 67)b   PH: 27 ±4.3 (19 to 29)b  
     GCT: 5/15 (33%)   PF:53 ±12.7 (35 to 72)b   PF: 27 ±4.0 (18 to 29)b  
  1. ABC, aneurysmal bone cyst; ABC-R, recurrent aneurysmal bone cyst; BC, bone cement augmentation; BG, bone grafting; CBT, chondroblastoma; F, female; GCT, giant-cell tumor of bone; IC, extended curettage; M, male; PH, proximal humerus; PF, proximal femur.
  2. aPostsurgical scores and ratings after recurrence prior to secondary surgery; bmean ±SD (range); ctwo recurrent cases.